González-Lahoz J - Search Results

1

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

de Mendoza C, Jiménez-Nacher I, Garrido C, Barreiro P, Poveda E, Corral A, Zahonero N, González-Lahoz J, Soriano V. de Mendoza C, et al. Clin Infect Dis. 2008 Jun 1;46(11):1782-5. doi: 10.1086/588045. Clin Infect Dis. 2008. PMID: 18426370

2

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.

de Mendoza C, Soriano V, González-Lahoz J. de Mendoza C, et al. Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):604-5. doi: 10.1007/s100960050358. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10517203 No abstract available.

3

Tolerability of abacavir in the clinical setting.

Martín-Carbonero L, Barreiro P, Soriano V, González-Lahoz J. Martín-Carbonero L, et al. Clin Microbiol Infect. 2000 Nov;6(11):621-2. doi: 10.1046/j.1469-0691.2000.00162.x. Clin Microbiol Infect. 2000. PMID: 11168068 Free article. No abstract available.

4

Is there a role for indinavir twice-daily in clinical practice?

Barreiro P, Soriano V, Cabello N, González-Lahoz J. Barreiro P, et al. Clin Microbiol Infect. 2000 Mar;6(3):152-4. doi: 10.1046/j.1469-0691.2000.00034-3.x. Clin Microbiol Infect. 2000. PMID: 11168093 Free article. No abstract available.

5

Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.

Martín JC, Soriano V, Jiménez-Nácher I, Martínez P, González-Lahoz J. Martín JC, et al. Clin Microbiol Infect. 2001 Dec;7(12):678-81. doi: 10.1046/j.1469-0691.2001.00340.x. Clin Microbiol Infect. 2001. PMID: 11843909 Free article.

6

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

Gallego L, Barreiro P, del Río R, González de Requena D, Rodríguez-Albariño A, González-Lahoz J, Soriano V. Gallego L, et al. Clin Infect Dis. 2004 Feb 1;38(3):430-2. doi: 10.1086/380791. Epub 2004 Jan 9. Clin Infect Dis. 2004. PMID: 14727217

7

Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.

de Mendoza C, Martín-Carbonero L, Gallego O, Corral A, González-Lahoz J, Soriano V. de Mendoza C, et al. J Med Virol. 2005 May;76(1):1-6. doi: 10.1002/jmv.20316. J Med Virol. 2005. PMID: 15778973

8

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

Rodriguez-Novoa S, Barreiro P, Rendón A, Jiménez-Nacher I, González-Lahoz J, Soriano V. Rodriguez-Novoa S, et al. Clin Infect Dis. 2005 May 1;40(9):1358-61. doi: 10.1086/429327. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825040

9

Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption.

Barreiro P, de Mendoza C, González-Lahoz J, Soriano V. Barreiro P, et al. Clin Infect Dis. 2005 Sep 15;41(6):897-900. doi: 10.1086/432887. Epub 2005 Aug 1. Clin Infect Dis. 2005. PMID: 16107992

10

Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.

Soriano V, Ramos B, Nunez M, Barreiro P, Maida I, Garcia-Samaniego J, Gonzalez-Lahoz J. Soriano V, et al. J Infect Dis. 2005 Oct 1;192(7):1245-8. doi: 10.1086/444468. Epub 2005 Aug 24. J Infect Dis. 2005. PMID: 16136468 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters